IF was performed as reported previously.
23 (link) Incubation with primary antibodies
CD271-PE (Miltenyi, Bergisch Gladbach, Germany, clone ME20.4-1.H4, mouse IgG1, 1:100),
γH2AX (1:250, Cell Signaling Technology), NFκB/p65 and p53 (Cell Signaling Technology, 1:100) or
TRITC-labeled phalloidin (1:1000, Sigma-Aldrich) diluted in blocking buffer was done overnight at 4 °C. Second day, cells were washed 3x with phosphate-buffered saline, and incubated with secondary antibodies AlexaFluor488/555 or 594 (1:500) recognizing either rabbit or mouse-produced antibodies and
4′,6-diamidin-2-phenylindol (Sigma-Aldrich, 1:500) for 1 h at room temperature. Washed cells were covered with 500 μl phosphate-buffered saline and used for microscopy. IF pictures were recorded with Zeiss
Axiovert40CFL with accompanied Illuminator HPX120C and software
AxioVision Rel. 4.8 (all Carl Zeiss AG, Oberkochen, Germany).
Redmer T., Walz I., Klinger B., Khouja S., Welte Y., Schäfer R, & Regenbrecht C. (2017). The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells. Oncogenesis, 6(1), e291-.